oral SGLT2 inhibitor - GC Pharma (Green Cross)

oral SGLT2 inhibitor

Clinical candidate for diabetes

from literature SGLT2 inhibitor

Bioorganic Med. Chem. Lett.

GC Pharma (Green Cross)

Context. GCC5694A (GC Pharma (Green Cross)) is an oral SGLT2 inhibitor. SGLT2 inhibitors help glycemic control in diabetes by preventing reabsorption of glucose in the kidney. Dapagliflozin was the…


 this content is exclusive to
Premium members

Unlock this content with a Premium membership to read it now.